Comparison of delayed release 5 aminosalicyclic acid (mesazaline) and sulphalazine in the treatment of mild to moderate ulcerative colitis relapse

Gut

Volumn 29, Issue 5, 1988, Pages 669-674

  Riley, S A ^a   Mani, V ^a   Goodman, M J ^a   Herd, M E ^a   Dutt, S ^a   Turnberg, L A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE; SULFALAZINE;

DEFECATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SIGMOIDOSCOPY; ULCERATIVE COLITIS;

EID: 0023920745     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.29.5.669     Document Type: Article

References (2)

1. Misiewicz, J.J.; Lennard-Jones, J.E.; Connell, A.M.; Parson, J.H.; Avery-Jones, F. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis Lancet 1965 i: 185
2. Dissanayake, A.S.; Truelove, S.C. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin) Gut 1973 10.1136/gut.14.12.923 14 923
3. AK, Azad Khan; DT, Howes; J, Piris; SC, Truelove Optimum dose of sulphasalazine for maintenance treatment of ulcerative colitis Gut 1980 21 232
4. Lennard-Jones, J.E.; Longmore, A.J.; Newell, A.C.; Wilson, C.W.E.; Avery Jones, F. An assessment of prednisolone, salazopyrine and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis Gut 1960 217 1
5. Baron, J.H.; Connell, A.M.; Lennard-Jones, J.E.; AveryJones, F.A. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis Lancet 1962 i: 1094
6. Dick, A.P.; Grayson, M.J.; Carpenter, R.G.; Petrie, A. Controlled trial of sulphasalazine in the treatment of ulcerative colitis Gut 1964 10.1136/gut.5.5.437 5 437
7. Taffet, S.L.; Sulfasalazine, Das K.M. Adverse effects and desensitization Dig Dis Sci 1983 28 833
8. Das, K.M.; Eastwood, M.A.; McManus, J.P.A.; Sircus, W. Adverse reactions during salicylazosulphapyridine therapy and the relation with drug metabolism and acetylator phenotype N EnglJ Med 1973 10.1056/NEJM197309062891001 289 491
9. AK, Azad Khan; J, Piris; SC, Truelove An experiment to determine the active therapeutic moiety of sulphasalazine Lancet 1977 ii: 892
10. PAM, Van Hees; JH, Bakker; van Tongeren JHM Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine Gut 1980 21 632
11. Klotz, U.; Maier, K.; Fischer, C.; Heinkel, K. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease N EnglJ Med 1980 10.1056/NEJM198012253032602 303 1499
12. Campieri, N.; Lanfranchi, G.A.; Bazzochi, G. Treatment of ulcerative colitis with high-dose 5aminosalicyclic acid enemas Lancet 1981 ii: 270
13. Campieri, N.; Lanfranchi, G.; Brignola, C.; Bazzocchi, G.; Minguzzi, M.; Calari, M. 5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine Lancet 1984 i: 403
14. Sutherland, L.R.; Martin, F.; Greer, S. 5aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis Gastroenterology 1987 10.1016/0016-5085(87)90621-4 92 1894
15. Nielson, O.H.; Bondesen, S. Kinetics of 5-aminosalicylic acid after jejunal instillation in man Br J Clin Pharmacol 1983 10.1111/j.1365-2125.1983.tb02254.x 16 738
16. Campieri, M.; Lanfranchi, G.A.; Boschi, S. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion Gut 1985 10.1136/gut.26.4.400 26 400
17. Lehmann, K. Programmed drug release from oral dosage forms Pharmacol Int 1971 3 1
18. Bown, R.L.; Gibson, J.A.; Sladen, G.E.; Hicks, B.; Dawson, A.M. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device Gut 1974 10.1136/gut.15.12.999 15 999
19. Dew, M.J.; Hughes, P.J.; Lee, M.G.; Evans, B.K.; Rhodes, J. An oral preparation to release drugs in the human colon Br J Clin Pharmacol 1982 10.1111/j.1365-2125.1982.tb01999.x 14 405
20. Truelove, S.C.; Watkins, G.; Draper, G. Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis Br Med J 1962 10.1136/bmj.2.5321.1708 ii: 1708
21. Watkinson, G. Medical management of ulcerative colitis Br Med J 1961 10.1136/bmj.1.5220.147 i: 147
22. Calder, I.C.; Funder, C.C.; Green, C.R.; Ham, K.N.; Tange, J.D. The comparative nephrotoxicity of aspirin and phenacetin derivatives Br Med J 1971 iv: 518
23. Calder, I.C.; Funder, C.C.; Green, C.R.; Ham, K.N.; Tange, J.D. Nephrotoxic lesions from 5-aminosalicylic acid Br Med J 1972 i: 152
24. Briggs, D.; Calder, I.C.; Woods, R.; Tange, J.D. The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat Pathology 1982 10.3109/00313028209092108 14 349
25. Schroeder, K.W.; Tremaine, W.J. Oral 5-aminosalicylic acid (Asacol) for treatment of symptomatic chronic ulcerative colitis Gastroenterology 1986 90 1620
26. Dew, M.J.; Harries, A.D.; Evans, N.; Evans, B.K.; Rhodes, J. Maintenance of remission in ulcerative colitis with 5amino salicylic acid in high doses by mouth Br Med J 1983 10.1136/bmj.287.6384.23 287 23
27. Diener, V.; Turzek, H.V.; Fischer, C.; Maier, K.; Klotz, U. Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man Arch Pharmacol 1984 10.1007/BF00505331 326 278
28. Donald, I.P.; Wilkins, S.P. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine Postgrad Med J 1985 10.1136/pgmj.61.722.1047 61 1047
29. Dew, M.J.; Harries, A.D.; Evans, B.K.; Rhodes, J. Treatment of ulcerative colitis with oral 5-aminosalicylic acid in patients unable to take sulphasalazine Lancet 1983
30. Riley, S.A.; Le Carpentier, J.; Mani, V.; Goodman, M.J.; Mandal, B.K.; Turnberg, L.A. Sulphasalazine-induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution Gut 1987 10.1136/gut.28.8.1008 28 1008
31. Dew, M.J.; Hughes, P.; Harries, A.D.; Williams, G.; Evans, B.K.; Rhodes, J. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid Br Med J 1982 10.1136/bmj.285.6347.1012 285 1012
32. Riley, S.A.; Mani, V.; Goodman, M.J.; Turnberg, L.A. A comparison of delayed-release 5-aminosalicylic acid and sulphasalazine as maintenance treatment of ulcerative colitis Gastroenterology 1987 92 1596